USD
+$0.00
(+0.00%
)At Close (As of Oct 21, 2025)
$354.77M
Market Cap
-
P/E Ratio
-1.9
EPS
$10.08
52 Week High
$1.10
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | -$713K |
Total Revenue | $0 |
Cost Of Revenue | $713K |
Costof Goods And Services Sold | $713K |
Operating Income | -$64M |
Selling General And Administrative | $16M |
Research And Development | $48M |
Operating Expenses | $64M |
Investment Income Net | - |
Net Interest Income | $2.6M |
Interest Income | $2.6M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $385K |
Income Before Tax | -$61M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$61M |
Comprehensive Income Net Of Tax | - |
Ebit | -$64M |
Ebitda | -$64M |
Net Income | -$61M |
Field | Value (USD) |
---|---|
Total Assets | $53M |
Total Current Assets | $40M |
Cash And Cash Equivalents At Carrying Value | $36M |
Cash And Short Term Investments | $36M |
Inventory | - |
Current Net Receivables | - |
Total Non Current Assets | $13M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $350K |
Intangible Assets Excluding Goodwill | $350K |
Goodwill | $6.7M |
Investments | - |
Long Term Investments | - |
Short Term Investments | -$36B |
Other Current Assets | $3.4M |
Other Non Current Assets | - |
Total Liabilities | $11M |
Total Current Liabilities | $7.5M |
Current Accounts Payable | $2M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $677K |
Total Non Current Liabilities | $3.8M |
Capital Lease Obligations | $4.2M |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $4.2M |
Other Current Liabilities | $4.9M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $41M |
Treasury Stock | - |
Retained Earnings | -$224M |
Common Stock | $31K |
Common Stock Shares Outstanding | $30M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$55M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $385K |
Capital Expenditures | $85K |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | $26M |
Cashflow From Financing | $5.3M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$61M |
Field | Value (USD) |
---|---|
Gross Profit | -$713K |
Total Revenue | $0 |
Cost Of Revenue | $713K |
Costof Goods And Services Sold | $713K |
Operating Income | -$64M |
Selling General And Administrative | $16M |
Research And Development | $48M |
Operating Expenses | $64M |
Investment Income Net | - |
Net Interest Income | $2.6M |
Interest Income | $2.6M |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $385K |
Income Before Tax | -$61M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$61M |
Comprehensive Income Net Of Tax | - |
Ebit | -$64M |
Ebitda | -$64M |
Net Income | -$61M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
None